Levanger Hospital is a hospital located in the town of Levanger in the municipality of Levanger in Trøndelag county, Norway. The hospital is located along the road Kirkegata on the west side of the town of Levanger. Along with Namsos Hospital, this is one of two hospitals in the old Nord-Trøndelag county.

During the past decade, Levanger Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Levanger Hospital" #1 sponsor was "Norwegian University of Science and Technology" with 15 trials, followed by "Helse Nord-Trøndelag HF" with 3 trials sponsored, "Oslo University Hospital" with 3 trials sponsored, "St. Olavs Hospital" with 3 trials sponsored and "Mode Sensors AS" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Levanger Hospital" #1 collaborator was "Helse Nord-Trøndelag HF" with 18 trials as a collaborator, "St. Olavs Hospital" with 14 trials as a collaborator, "Alesund Hospital" with 8 trials as a collaborator, "Haukeland University Hospital" with 7 trials as a collaborator and "University Hospital of North Norway" with 7 trials as a collaborator. Other collaborators include 130 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Levanger Hospital" are "Stroke" (4 trials), "Ischemic Attack, Transient" (3 trials), "Cardiovascular Diseases" (2 trials), "Cerebrovascular Accident" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "Levanger Hospital" in a lesser frequency.

Most popular intervention types in "Levanger Hospital" are "Other" (9 trials), "Behavioral" (8 trials), "Drug" (8 trials), "Procedure" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials), "45 Gy in 30 fractions" (1 trials) and "60 Gy in 40 fractions" (1 trials). Other intervention names were less common.

The vast majority of trials in "Levanger Hospital" are 31 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Levanger Hospital". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Levanger Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Levanger Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".